Allo-Advantage was formed to facilitate the distribution of quality biologic grafts to surgical facilities for patients in need of life saving and life enhancing procedures. We
have more than 19 years of experience in recovery,
production, operations and distribution, and our organization is
registered with the Food and Drug Administration (FDA).
Our goal is to provide the safest, most clinically effective
allografts available with focus on supply chain management with the
highest respect to the donors, donor families and the
recipients who benefit from these gifts. The well-being of graft
recipients is a top priority to us so we take every possible
precaution to ensure the safety and integrity of the grafts. All
of our processing partners adhere to the highest industry
standards, and we work closely with them to ensure safety and efficacy
of transplant grafts.
Allo-Advantage places customer service as a high priority and we take
pride in working with our clients to aquire difficult to locate grafts
and partnering with your facilities to improve upon your supply chain
management and cost effectiveness.
clean environment.
We strive to provide the finest allograft products to the surgical
community at competitive pricing, in-order to maximize the gift of
donation as well as the health of the recipient.
Allo-Advantage rigorously maintains technical quality assurance standards. Our allografts are prepared from tissue procured from donated human tissue using aseptic surgical techniques. Processing, cleaning, cutting, sizing, shaping and sterilization are performed using aseptic techniques in a controlled, ultra clean environment.
Our innovative supply chain Processes are designed to establish and maintain sterility through a variety of in-process measures. We supply grafts that meet or exceed American Association of Tissue Bank (AATB) standards. Allo-Advantage maintains strict standards for microbiological and sterility testing performed by laboratories that are registered with the FDA, and CLIA. All tissue must pass stringent testing before it can be released for transplantation.